Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to register for free online access

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
Journal of Biomolecular Screening
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (4)
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Leung, S.
Right arrow Articles by Perez, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leung, S.
Right arrow Articles by Perez, D.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Differential Inhibition of Inducible T Cell Cytokine Secretion by Potent Iron Chelators

Stewart Leung

Berlex Biosciences, Richmond, CA

April Holbrook

Berlex Biosciences, Richmond, CA

Beverly King

Berlex Biosciences, Richmond, CA

Hong-Tao Lu

Berlex Biosciences, Richmond, CA

Vincent Evans

Berlex Biosciences, Richmond, CA

Neil Miyamoto

Berlex Biosciences, Richmond, CA

Cornell Mallari

Berlex Biosciences, Richmond, CA

Susan Harvey

Berlex Biosciences, Richmond, CA

Dave Davey

Berlex Biosciences, Richmond, CA

Elena Ho

Berlex Biosciences, Richmond, CA

Wei-Wei Li

Berlex Biosciences, Richmond, CA

John Parkinson

Berlex Biosciences, Richmond, CA

Richard Horuk

Berlex Biosciences, Richmond, CA

Stefan Jaroch

Schering AG, Berlin, Germany

Markus Berger

Schering AG, Berlin, Germany

Werner Skuballa

Schering AG, Berlin, Germany

Christopher West

Berlex Biosciences, Richmond, CA

Rebecca Pulk

Berlex Biosciences, Richmond, CA

Gary Phillips

Berlex Biosciences, Richmond, CA

Judi Bryant

Berlex Biosciences, Richmond, CA

Babu Subramanyam

Berlex Biosciences, Richmond, CA

Caralee Schaefer

Berlex Biosciences, Richmond, CA

Hugh Salamon

Berlex Biosciences, Richmond, CA

Eric Lyons

Berlex Biosciences, Richmond, CA

Daniela Schilling

Schering AG, Berlin, Germany

Henrik Seidel

Schering AG, Berlin, Germany

Joern Kraetzschmar

Schering AG, Berlin, Germany

Michael Snider

Berlex Biosciences, Richmond, CA

Daniel Perez

Berlex Biosciences, Richmond, CA

Effector functions and proliferation of T helper (Th) cells are influenced by cytokines in the environment. Th1 cells respond to a synergistic effect of interleukin-12 (IL-12) and interleukin-18 (IL-18) to secrete interferon-gamma (IFN-{gamma}). In contrast, Th2 cells respond to interleukin-4 (IL-4) to secrete IL-4, interleukin-13 (IL-13), interleukin-5 (IL-5), and interleukin-10 (IL-10). The authors were interested in identifying nonpeptide inhibitors of the Th1 response selective for the IL-12/IL-18-mediated secretion of IFN-{gamma} while leaving the IL-4-mediated Th2 cytokine secretion relatively intact. The authors established a screening protocol using human peripheral blood mononuclear cells (PBMCs) and identified the hydrazino anthranilate compound 1 as a potent inhibitor of IL-12/IL-18-mediated IFN-{gamma} secretion from CD3+ cells with an IC50 around 200 nM. The inhibitor was specific because it had virtually no effect on IL-4-mediated IL-13 release from the same population of cells. Further work established that compound 1 was a potent intracellular iron chelator that inhibited both IL-12/IL-18- and IL-4-mediated T cell proliferation. Iron chelation affects multiple cellular pathways in T cells. Thus, the IL-12/IL-18-mediated proliferation and IFN-{gamma} secretion are very sensitive to intracellular iron concentration. However, the IL-4-mediated IL-13 secretion does not correlate with proliferation and is partially resistant to potent iron chelation

Key Words: Th1 response • iron chelators • T helper cells • cytokines

Journal of Biomolecular Screening, Vol. 10, No. 2, 157-167 (2005)
DOI: 10.1177/1087057104272394
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Mult SclerHome page
K.M. Mitchell, A.L. Dotson, K.M. Cool, A. Chakrabarty, S.H. Benedict, and S.M. LeVine
Deferiprone, an orally deliverable iron chelator, ameliorates experimental autoimmune encephalomyelitis
Multiple Sclerosis, November 1, 2007; 13(9): 1118 - 1126.
[Abstract] [PDF]